Drug major Dr Reddy’s Laboratories on Thursday reported a 69.41 per cent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
The company had posted a profit of Rs 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs 3,357.45 crore from Rs 2,880.85 crore a year earlier, Dr Reddy’s Laboratories said in a BSE filing. Revenue from the global generics segment grew 32 per cent to Rs 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
ADVERTISEMENT
Shares of Dr Reddy’s Laboratories were down 2.52 per cent at Rs 2,459.20 on the BSE in late afternoon trade.
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.